Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WiseGain Medical is a Shanghai-based medical device company specializing in the development and manufacturing of high-end interventional products for vascular diseases. The company's portfolio primarily focuses on "precision intervention" and "stent-free" solutions, including drug-coated balloons (DCB) and PTCA balloon catheters. Their flagship products are designed for coronary, peripheral, and neurovascular applications, aiming to treat complex lesions while minimizing the need for permanent implants. WiseGain has successfully obtained NMPA approvals for several core products in China and continues to expand its pipeline in the cardiovascular and endovascular space. The company is backed by prominent venture capital firms and maintains a strong focus on R&D and clinical validation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai WiseGain Medical Devices.